Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9487 |
High Similarity |
NPD6166 |
Phase 2 |
0.9487 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.9487 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.9342 |
High Similarity |
NPD1934 |
Approved |
0.9281 |
High Similarity |
NPD2801 |
Approved |
0.9187 |
High Similarity |
NPD7054 |
Approved |
0.9156 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.913 |
High Similarity |
NPD7472 |
Approved |
0.9097 |
High Similarity |
NPD3817 |
Phase 2 |
0.9067 |
High Similarity |
NPD1511 |
Approved |
0.9012 |
High Similarity |
NPD7074 |
Phase 3 |
0.9006 |
High Similarity |
NPD3818 |
Discontinued |
0.8963 |
High Similarity |
NPD7808 |
Phase 3 |
0.8961 |
High Similarity |
NPD4380 |
Phase 2 |
0.8957 |
High Similarity |
NPD6797 |
Phase 2 |
0.8947 |
High Similarity |
NPD1512 |
Approved |
0.8917 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8917 |
High Similarity |
NPD3882 |
Suspended |
0.8902 |
High Similarity |
NPD7251 |
Discontinued |
0.8861 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8848 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8636 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8636 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8616 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8543 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8543 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8528 |
High Similarity |
NPD6232 |
Discontinued |
0.8519 |
High Similarity |
NPD5494 |
Approved |
0.8509 |
High Similarity |
NPD7075 |
Discontinued |
0.8503 |
High Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.85 |
High Similarity |
NPD5402 |
Approved |
0.8494 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8494 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8491 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8487 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8485 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8477 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8466 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8428 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8411 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8408 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8333 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8323 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.828 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8235 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.821 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8146 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8098 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8095 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8063 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.8039 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8036 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.8026 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8026 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8025 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8024 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.8013 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7947 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7917 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7911 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7908 |
Intermediate Similarity |
NPD943 |
Approved |
0.7904 |
Intermediate Similarity |
NPD919 |
Approved |
0.7848 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7844 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7824 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7809 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7799 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7791 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7791 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7778 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7765 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7764 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7763 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.775 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7747 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7742 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7742 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7711 |
Intermediate Similarity |
NPD37 |
Approved |
0.7697 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7688 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7679 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7679 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7679 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7658 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7654 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7647 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7627 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7627 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7625 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7624 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7614 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7607 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7607 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7607 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7607 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7595 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7586 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7571 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7548 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7542 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.753 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7527 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7515 |
Intermediate Similarity |
NPD920 |
Approved |
0.75 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7484 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7468 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7468 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7458 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7446 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7446 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7438 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7438 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7436 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7434 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7419 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7407 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7396 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7396 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7394 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7394 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7389 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7383 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7382 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7378 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7375 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7353 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7345 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.734 |
Intermediate Similarity |
NPD6779 |
Approved |
0.734 |
Intermediate Similarity |
NPD6780 |
Approved |
0.734 |
Intermediate Similarity |
NPD6781 |
Approved |
0.734 |
Intermediate Similarity |
NPD6776 |
Approved |
0.734 |
Intermediate Similarity |
NPD6778 |
Approved |
0.734 |
Intermediate Similarity |
NPD6782 |
Approved |
0.734 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7338 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7325 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7321 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7318 |
Intermediate Similarity |
NPD7038 |
Approved |
0.7318 |
Intermediate Similarity |
NPD7039 |
Approved |
0.7317 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7308 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7308 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7303 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7301 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7299 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7296 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7284 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7244 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7231 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7231 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7225 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7222 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7216 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7215 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7209 |
Intermediate Similarity |
NPD5353 |
Approved |
0.719 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.719 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7188 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7188 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7188 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7182 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7179 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7178 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7161 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7159 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7152 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7135 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7135 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7135 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7135 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7135 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7128 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7128 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7118 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7115 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7097 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7097 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7095 |
Intermediate Similarity |
NPD2163 |
Approved |
0.7091 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7086 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7083 |
Intermediate Similarity |
NPD4661 |
Approved |
0.7083 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7083 |
Intermediate Similarity |
NPD4662 |
Approved |
0.7081 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7077 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7074 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7074 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7062 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7062 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7055 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7041
|
Intermediate Similarity |
NPD6273 |
Approved |